The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Landis G. Michael since 2015.
This trader's CIK number is 1548560.
At the time of last reporting, Landis G. Michael was the Chief Financial Officer of Polaryx Therapeutics, Inc.. (stock ticker symbol PLYX).
Also see all insider trading activities at Polaryx Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | LCI | 0 | $0 | 11,120 | $366,687 | 10,667 | $117,129 |
| 2015 | LCI | 0 | $0 | 23,549 | $1,310,745 | 10,333 | $74,294 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | PLYX | 2,867 | $7,990 | 0 | $0 | 0 | $0 |
2. Polaryx Therapeutics, Inc. (PLYX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-15 | LCI | Sale | 4,334 | 32.30 | 139,988 |
| 2016-09-15 | LCI | Option Ex | 4,334 | 13.86 | 60,069 |
| 2016-08-31 | LCI | Sale | 6,786 | 33.41 | 226,699 |
| 2016-08-31 | LCI | Option Ex | 6,333 | 9.01 | 57,060 |
| 2015-02-17 | LCI | Sale | 11,500 | 58.61 | 673,980 |
| 2015-02-06 | LCI | Sale | 12,049 | 52.85 | 636,765 |
| 2015-02-06 | LCI | Option Ex | 10,333 | 7.19 | 74,294 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-18 | PLYX | Buy | 2,867 | 2.79 | 7,990 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Landis G. Michael (Chief Financial Officer of Polaryx Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.